G Kourtis1, A S Rucco, F Loconte, M F Caiaffa, L Macchia. Show Affiliations » 1. Department of Allergology and Clinical Immunology, University of Bari, Bari, Italy.
Abstract
Entities: Chemical Disease
Mesh: See more » AgedAntibodies, Anti-IdiotypicAntibodies, Monoclonal/administration & dosageAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, HumanizedAsthma/diagnosisAsthma/drug therapyAsthma/physiopathologyCoughFemaleHumansMaleMiddle AgedMonitoring, Physiologic/instrumentationMonitoring, Physiologic/methodsOmalizumabPeak Expiratory Flow RateRecovery of FunctionRespiratory SoundsRetrospective Studies
Substances: See more » Antibodies, Anti-IdiotypicAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedOmalizumab
Year: 2010 PMID: 20945619
Source DB: PubMed Journal: J Investig Allergol Clin Immunol ISSN: 1018-9068 Impact factor: 4.333